A solution for activating or suppressing immune responses to any antigen.
Scientific principles underlying technology platforms
In vivo characterization of the physicochemical properties of polymers-linked TLR agonists that enhance vaccine immunogenicity.
Description of SNAPvax as a platform for promoting T cell immunity
Peptide-TLR-7/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumor antigens.
Immunological mechanisms for enhanced efficacy by intravenous vaccination
Intravenous nanoparticle vaccination generates stem-like TCF1+ neoantigen-specific CD8+ T cells.